l-carnitine for mitochondrial disease The carnitine system and cancer metabolic plasticity Carnitine Shuttle | Purpose and

As the FT4 level increased, ALA, TYR, C14, and C16:1 decreased, whereas VAL, C0, C2, C3, C3DC+C4OH, C5, C6DC, and C12 increased

Carnitine is a central metabolite in the mitochondrial carnitine cycle/fatty acid oxidation pathway, in the transfer to mitochondria of the end products of peroxisomal fatty acid oxidation, and in Coenzyme A homeostasis

However, although testosterone does indeed modulate GnRH release by controlling the pulsatile nature of the secretions 21 , the mechanism for the fine control has remained somewhat elusive, mainly due to the GnRH secreting neurons not expressing AR or ER 22

In the hepatic metabolome, we noticed alterations in certain lipid metabolites, such as acylcarnitines or phosphatidylcholines, occurring before the onset of obesity, reminiscent of similar (and hitherto unexplained) changes detected in the serum of obese AS patients 39